CAS: 1884461-72-6; (E)-1-(2-(2-(Mesitylimino)-9,10-Dimethoxy-4-Oxo-6,7-Dihydro-2H-Pyrimido[6,1-A]Isoquinolin-3(4H)-yl)Ethyl)Urea

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:CN-120004884-A
    优先权日:2024-09-18
    标题 :Enzefin Synthesis process of statin

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Donohue JF, Rheault T, MacDonald-Berko M, Bengtsson T, Rickard K. Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD. Int J Chron Obstruct Pulmon Dis. 2023 Jul 28;18:1611-1622. doi: 10.2147/COPD.S413436.
    2: Stolfa I, Page C. Phosphodiesterase inhibitors and lung diseases. Adv Pharmacol. 2023;98:55-81. doi: 10.1016/bs.apha.2023.05.001. Epub 2023 May 26. 208(4):344-346. doi: 10.1164/rccm.202307-1164ED.
    4: Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, Sciurba F. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials). Am J Respir Crit Care Med. 2023 Aug 15;208(4):406-416. doi: 10.1164/rccm.202306-0944OC.

    合成参考文献


    摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2025).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知